1. Prevalence of risk factors at presentation and early mortality in patients aged 80 years or older with ST-segment elevation myocardial infarction
- Author
-
Jan Eritsland, Sigrun Halvorsen, Michael Abdelnoor, Kristin M Kvakkestad, and Peter Andreas Claussen
- Subjects
Male ,medicine.medical_specialty ,Pathology ,Endocrinology, Diabetes and Metabolism ,Myocardial Infarction ,elderly patients ,Angina ,Cohort Studies ,chemistry.chemical_compound ,Electrocardiography ,Age Distribution ,Risk Factors ,Internal medicine ,medicine ,Prevalence ,Humans ,Pharmacology (medical) ,Myocardial infarction ,Prospective Studies ,Sex Distribution ,Prospective cohort study ,Stroke ,Original Research ,Aged ,octogenarian ,Aged, 80 and over ,Creatinine ,business.industry ,Norway ,total cholesterol ,Public Health, Environmental and Occupational Health ,creatinine ,Hematology ,General Medicine ,Odds ratio ,medicine.disease ,mortality ,Confidence interval ,Hospitals ,Vascular Health and Risk Management ,ST-segment elevation myocardial infarction ,Cholesterol ,chemistry ,Population study ,Female ,Cardiology and Cardiovascular Medicine ,business - Abstract
Peter Andreas Claussen,1,2 Michael Abdelnoor,3 Kristin M Kvakkestad,1,2 Jan Eritsland,1 Sigrun Halvorsen1 1Department of Cardiology, Oslo University Hospital, Ullevaal, Norway; 2Faculty of Medicine, University of Oslo, Oslo, Norway; 3Centre of Clinical Research: Unit of Epidemiology and Biostatistics, Oslo University Hospital, Ullevaal, Norway Background: Elderly patients with ST-segment elevation myocardial infarction (STEMI) are at high risk for complications and early mortality; still, they are underrepresented in clinical trials and observational studies. We studied the risk profiles at presentation and early mortality in elderly (≥80 years) versus younger (
- Published
- 2014